{"entity":{"type":"insider","cik":"0001711080","url":"/insider/0001711080","json_url":"/insider/0001711080.json","name":"Grunberg Gregory","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":6,"n_filings":6,"first":"2017-07-26","last":"2021-04-23","span_basis":"filed_date"},"name_variants":[{"name":"Grunberg Gregory","source":"filing","n_filings":6,"first_seen":"2017-07-26","last_seen":"2021-04-23"}],"transactions":[{"id":5363682,"accession":"0000899243-21-016878","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-21-016878","line_url":"/filing/0000899243-21-016878#line-1","is_derivative":false,"issuer_cik":"0001711080","issuer_name":"89bio, Inc.","issuer_ticker":"ETNB","issuer_name_source":null,"issuer_url":"/issuer/0001711080","owner_cik":"0001711080","owner_name":"Grunberg Gregory","owner_display_name":"Grunberg Gregory","owner_url":"/insider/0001711080","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":850.0,"shares_display":"850","price_per_share":27.6,"price_display":"27.60","price_state":"stated","total_value":23460.0,"total_display":"23,460.00","total_whole":"23,460","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-04-21","filed_date":"2021-04-23","scope":"insider"},{"id":3195358,"accession":"0000899243-20-019122","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-20-019122","line_url":"/filing/0000899243-20-019122#line-1","is_derivative":false,"issuer_cik":"0001711080","issuer_name":"89bio, Inc.","issuer_ticker":"ETNB","issuer_name_source":null,"issuer_url":"/issuer/0001711080","owner_cik":"0001711080","owner_name":"Grunberg Gregory","owner_display_name":"Grunberg Gregory","owner_url":"/insider/0001711080","role":"Director, Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":109090.0,"shares_display":"109,090","price_per_share":27.5,"price_display":"27.50","price_state":"stated","total_value":2999975.0,"total_display":"2,999,975.00","total_whole":"2,999,975","shares_owned_after":2600877.0,"shares_owned_after_display":"2,600,877","ownership_form":"I","is_10b5_1":null,"transaction_date":"2020-07-10","filed_date":"2020-07-14","scope":"insider"},{"id":2222554,"accession":"0001179110-20-003675","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001179110-20-003675","line_url":"/filing/0001179110-20-003675#line-1","is_derivative":false,"issuer_cik":"0001479419","issuer_name":"Kala Pharmaceuticals, Inc.","issuer_ticker":"KALA","issuer_name_source":null,"issuer_url":"/issuer/0001479419","owner_cik":"0001711080","owner_name":"Grunberg Gregory","owner_display_name":"Grunberg Gregory","owner_url":"/insider/0001711080","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2534854.0,"shares_display":"2,534,854","price_per_share":7.89,"price_display":"7.89","price_state":"stated","total_value":19999998.06,"total_display":"19,999,998.06","total_whole":"19,999,998","shares_owned_after":2534854.0,"shares_owned_after_display":"2,534,854","ownership_form":"I","is_10b5_1":null,"transaction_date":"2020-03-13","filed_date":"2020-03-16","scope":"insider"},{"id":8761959,"accession":"0000899243-19-027222","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-19-027222","line_url":"/filing/0000899243-19-027222#line-1","is_derivative":false,"issuer_cik":"0001711080","issuer_name":"89bio, Inc.","issuer_ticker":"ETNB","issuer_name_source":null,"issuer_url":"/issuer/0001711080","owner_cik":"0001711080","owner_name":"Grunberg Gregory","owner_display_name":"Grunberg Gregory","owner_url":"/insider/0001711080","role":"Director, Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":575000.0,"shares_display":"575,000","price_per_share":16.0,"price_display":"16.00","price_state":"stated","total_value":9200000.0,"total_display":"9,200,000.00","total_whole":"9,200,000","shares_owned_after":575000.0,"shares_owned_after_display":"575,000","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-11-11","filed_date":"2019-11-13","scope":"insider"},{"id":6491063,"accession":"0001179110-18-012105","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001179110-18-012105","line_url":"/filing/0001179110-18-012105#line-1","is_derivative":false,"issuer_cik":"0001479419","issuer_name":"Kala Pharmaceuticals, Inc.","issuer_ticker":"KALA","issuer_name_source":null,"issuer_url":"/issuer/0001479419","owner_cik":"0001711080","owner_name":"Grunberg Gregory","owner_display_name":"Grunberg Gregory","owner_url":"/insider/0001711080","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":606060.0,"shares_display":"606,060","price_per_share":8.25,"price_display":"8.25","price_state":"stated","total_value":4999995.0,"total_display":"4,999,995.00","total_whole":"4,999,995","shares_owned_after":2877006.0,"shares_owned_after_display":"2,877,006","ownership_form":"I","is_10b5_1":null,"transaction_date":"2018-10-05","filed_date":"2018-10-09","scope":"insider"},{"id":4334292,"accession":"0001179110-17-010704","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001179110-17-010704","line_url":"/filing/0001179110-17-010704#line-2","is_derivative":false,"issuer_cik":"0001479419","issuer_name":"Kala Pharmaceuticals, Inc.","issuer_ticker":"KALA","issuer_name_source":null,"issuer_url":"/issuer/0001479419","owner_cik":"0001711080","owner_name":"Grunberg Gregory","owner_display_name":"Grunberg Gregory","owner_url":"/insider/0001711080","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":215000.0,"shares_display":"215,000","price_per_share":15.0,"price_display":"15.00","price_state":"stated","total_value":3225000.0,"total_display":"3,225,000.00","total_whole":"3,225,000","shares_owned_after":2270946.0,"shares_owned_after_display":"2,270,946","ownership_form":"I","is_10b5_1":null,"transaction_date":"2017-07-25","filed_date":"2017-07-26","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":6,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":5,"open_market":true},{"code":"S","label":"Open-market sale","n":1,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":6},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001785173","name":"89bio, Inc.","url":"/issuer/0001785173","role":"Director, Ten percent owner","n_filings":3,"first_seen":"2019-11-13","last_seen":"2021-04-23"},{"type":"issuer","type_label":"ISSUER","cik":"0001479419","name":"Kala Pharmaceuticals, Inc.","url":"/issuer/0001479419","role":"Director","n_filings":3,"first_seen":"2017-07-26","last_seen":"2020-03-16"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001711080","retrieved_at":"2026-08-23T04:25:15+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}